Hepatitis C virus infection status among drug users in Baoshan District

Objective: To investigate the prevalence and influencing factors of hepatitis C virus (HCV) infection among drug users in Baoshan District, Shanghai Municipality, so as to provide insights into strengthening HCV intervention among drug users. Methods: Drug users under community management in Baoshan...

Full description

Saved in:
Bibliographic Details
Main Author: CHEN Jianshuang, ZHU Liming, LE Boxin, WANG Chengyi, LIU Xiaofeng, HE Fan
Format: Article
Language:zho
Published: Editorial Office of China Preventive Medicine Journal 2025-02-01
Series:预防医学
Subjects:
Online Access:http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2025.02.013
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850075292181200896
author CHEN Jianshuang, ZHU Liming, LE Boxin, WANG Chengyi, LIU Xiaofeng, HE Fan
author_facet CHEN Jianshuang, ZHU Liming, LE Boxin, WANG Chengyi, LIU Xiaofeng, HE Fan
author_sort CHEN Jianshuang, ZHU Liming, LE Boxin, WANG Chengyi, LIU Xiaofeng, HE Fan
collection DOAJ
description Objective: To investigate the prevalence and influencing factors of hepatitis C virus (HCV) infection among drug users in Baoshan District, Shanghai Municipality, so as to provide insights into strengthening HCV intervention among drug users. Methods: Drug users under community management in Baoshan District from 2017 to 2023 were recruited. Demographic information, drug use behaviors, sexual behaviors and receipt of intervention service were collected through questionnaire surveys. Blood samples were collected for HCV antibody testing, and the prevalence of anti-HCV antibody was analyzed. Factors affecting the prevalence of anti-HCV antibody among drug users were analyzed using a multivariable logistic regression model. Results: A total of 2 801 drug users were surveyed, including 2 233 males (79.72%) and 568 females (20.28%). The majority of drug users were aged 40 to <60 years (1 663 drug users, 59.37%). The prevalence of anti-HCV antibody was 28.35%, showing an overall upward trend from 2017 to 2023 (P<0.05). Multivariable logistic regression analysis showed that females (OR=1.468, 95%CI: 1.169-1.844), 40 years and over (40 to <50 years, OR=2.441, 95%CI: 1.838-3.242; 50 to <60 years, OR=2.377, 95%CI: 1.787-3.161; 60 to 97 years, OR=1.637, 95%CI: 1.163-2.304), using traditional drugs (OR=2.488, 95%CI: 1.967-3.147) or mixed drugs (OR=2.950, 95%CI: 1.974-4.409), having injected drugs (not share needles, OR=3.649, 95%CI: 2.849-4.673; share needles, OR=3.532, 95%CI: 1.851-6.738) and never using condoms during sexual contacts with spouses/cohabitants in the past year (OR=1.975, 95%CI: 1.354-2.879) were associated with a higher prevalence of anti-HCV antibody; the educational level of high school/technical secondary school (OR=0.483, 95%CI: 0.280-0.835) or college and above (OR=0.280, 95%CI: 0.129-0.608) was associated with a lower prevalence of anti-HCV antibody. Conclusions: The prevalence of anti-HCV antibody among drug users in Baoshan District showed an upward trend from 2017 to 2023. Gender, age, educational level, type of drugs, history of drug injection and never using condoms during sexual contacts with spouses/cohabitants were influencing factors for prevalence of anti-HCV antibody among drug users.
format Article
id doaj-art-7f8ab0a759804abcb283ba6fc7d1aac2
institution DOAJ
issn 2096-5087
language zho
publishDate 2025-02-01
publisher Editorial Office of China Preventive Medicine Journal
record_format Article
series 预防医学
spelling doaj-art-7f8ab0a759804abcb283ba6fc7d1aac22025-08-20T02:46:20ZzhoEditorial Office of China Preventive Medicine Journal预防医学2096-50872025-02-0137216817210.19485/j.cnki.issn2096-5087.2025.02.013Hepatitis C virus infection status among drug users in Baoshan DistrictCHEN Jianshuang, ZHU Liming, LE Boxin, WANG Chengyi, LIU Xiaofeng, HE FanObjective: To investigate the prevalence and influencing factors of hepatitis C virus (HCV) infection among drug users in Baoshan District, Shanghai Municipality, so as to provide insights into strengthening HCV intervention among drug users. Methods: Drug users under community management in Baoshan District from 2017 to 2023 were recruited. Demographic information, drug use behaviors, sexual behaviors and receipt of intervention service were collected through questionnaire surveys. Blood samples were collected for HCV antibody testing, and the prevalence of anti-HCV antibody was analyzed. Factors affecting the prevalence of anti-HCV antibody among drug users were analyzed using a multivariable logistic regression model. Results: A total of 2 801 drug users were surveyed, including 2 233 males (79.72%) and 568 females (20.28%). The majority of drug users were aged 40 to <60 years (1 663 drug users, 59.37%). The prevalence of anti-HCV antibody was 28.35%, showing an overall upward trend from 2017 to 2023 (P<0.05). Multivariable logistic regression analysis showed that females (OR=1.468, 95%CI: 1.169-1.844), 40 years and over (40 to <50 years, OR=2.441, 95%CI: 1.838-3.242; 50 to <60 years, OR=2.377, 95%CI: 1.787-3.161; 60 to 97 years, OR=1.637, 95%CI: 1.163-2.304), using traditional drugs (OR=2.488, 95%CI: 1.967-3.147) or mixed drugs (OR=2.950, 95%CI: 1.974-4.409), having injected drugs (not share needles, OR=3.649, 95%CI: 2.849-4.673; share needles, OR=3.532, 95%CI: 1.851-6.738) and never using condoms during sexual contacts with spouses/cohabitants in the past year (OR=1.975, 95%CI: 1.354-2.879) were associated with a higher prevalence of anti-HCV antibody; the educational level of high school/technical secondary school (OR=0.483, 95%CI: 0.280-0.835) or college and above (OR=0.280, 95%CI: 0.129-0.608) was associated with a lower prevalence of anti-HCV antibody. Conclusions: The prevalence of anti-HCV antibody among drug users in Baoshan District showed an upward trend from 2017 to 2023. Gender, age, educational level, type of drugs, history of drug injection and never using condoms during sexual contacts with spouses/cohabitants were influencing factors for prevalence of anti-HCV antibody among drug users.http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2025.02.013drug userhepatitis c virusinfluencing factor
spellingShingle CHEN Jianshuang, ZHU Liming, LE Boxin, WANG Chengyi, LIU Xiaofeng, HE Fan
Hepatitis C virus infection status among drug users in Baoshan District
预防医学
drug user
hepatitis c virus
influencing factor
title Hepatitis C virus infection status among drug users in Baoshan District
title_full Hepatitis C virus infection status among drug users in Baoshan District
title_fullStr Hepatitis C virus infection status among drug users in Baoshan District
title_full_unstemmed Hepatitis C virus infection status among drug users in Baoshan District
title_short Hepatitis C virus infection status among drug users in Baoshan District
title_sort hepatitis c virus infection status among drug users in baoshan district
topic drug user
hepatitis c virus
influencing factor
url http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2025.02.013
work_keys_str_mv AT chenjianshuangzhulimingleboxinwangchengyiliuxiaofenghefan hepatitiscvirusinfectionstatusamongdrugusersinbaoshandistrict